| Edit |   |
|---|
| Product Name | Mivebresib |
|---|
| Description | Mivebresib is a potent BET inhibitor with potential antineoplastic activity. It disrupts critical transcription programs that drive prostate cancer growth to induce potent anti-tumor activity in vitro and in vivo. MW: 459.47. Purity ≥98% by HPLC |
|---|
| Size | 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | N-(4-(2,4-difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl)ethanesulfonamide; ABBV-075 |
|---|
| Gene, Accession, CAS # | CAS: 1445993-26-9 |
|---|
| Catalog # | B1564-25 |
|---|
| Price | |
|---|
| Order / More Info | Mivebresib from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|